INDICATION AND USAGE Nifedipine extended-release tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.
Mylan Pharmaceuticals Inc.
HOW SUPPLIED Nifedipine Extended-Release Tablets, USP are available containing 30 mg, 60 mg or 90 mg of nifedipine, USP. The 30 mg tablets are white, film-coated, round, unscored tablets debossed with M on one side of the tablet and NE over 30 on the other side. They are available as follows: NDC 0378-0353-77 bottles of 90 tablets NDC 0378-0353-01 bottles of 100 tablets NDC 0378-0353-10 bottles of 1000 tablets The 60 mg tablets are orange, film-coated, round, unscored tablets debossed with M on one side of the tablet and NE over 60 on the other side. They are available as follows: NDC 0378-0360-77 bottles of 90 tablets NDC 0378-0360-01 bottles of 100 tablets NDC 0378-0360-10 bottles of 1000 tablets The 90 mg tablets are pink, film-coated, round, unscored tablets debossed with M on one side of the tablet and NE over 90 on the other side. They are available as follows: NDC 0378-0390-77 bottles of 90 tablets NDC 0378-0390-01 bottles of 100 tablets Store at 20Â° to 25Â°C (68Â° to 77Â°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. The brands listed are trademarks of their respective owners. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 7/2018 NIFECC:R4
High Cholesterol puts you at risk for and , two leading causes of death in the US. There are ways to control your cholesterol levels.
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site